PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor
NCT05156515
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Melanoma
PD-L1
PET/CT
Interventions
DIAGNOSTIC_TEST:
68Ga-THP-APN09
Sponsor
Peking University Cancer Hospital & Institute